Patents by Inventor Peter Lees

Peter Lees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6232496
    Abstract: Amphoacetate surfactants are made by reacting a compound of formula RCONHCH2CH2NHCH2CH2OH where R is an aliphatic radical, with formaldehyde and a cyanide of formula: R1CN, wherein R1 represents a hydrogen atom or an alkali metal, and, when R1 represents a hydrogen atom, hydrolysing the nitrile obtained with an alkali.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: May 15, 2001
    Assignee: Rhone-Poulenc Chemicals Limited
    Inventors: John F. Carr, Peter Lees, Richard Stocks-Wilson, Derek Pakenham
  • Patent number: 6057282
    Abstract: Imadazoline-based amphoacetates of higher purity, containing essentially negligible amounts of unalkylated amido amines, lower amounts of glycolic acid salts and monochloroacetate salts, superior to currently available conventional amphoacetates, are provided. This is demonstrated by their improved surface-active properties. Lower inherent irritation properties may be expected due to improved purity.The higher purity amphoacetates can be obtained via processes utilizing precise pH control during the reaction of imidazoline, or its open-chain derivatives, with alkylating agents, e.g. sodium monochloroacetate. The pH can be controlled by adding the base slowly or automatically in response to a pH metering device to maintain a constant pH, or by a series of staged additions which are calculated to maintain pH within a stated range. The reaction may also be carried out by conducting the initial hydrolysis of the imidazoline ring structure, followed by alkylation.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: May 2, 2000
    Assignee: Rhodia Inc.
    Inventors: Bharat Desai, Peter Lees, Jean-Marc Ricca, David J. Tracy
  • Patent number: 5952291
    Abstract: Imadazoline-based amphoacetates of higher purity, containing essentially negligible amounts of unalkylated amido amines, lower amounts of glycolic acid salts and monochloroacetate salts, superior to currently available conventional amphoacetates, are provided. This is demonstrated by their improved surface-active properties. Lower inherent irritation properties may be expected due to improved purity.The higher purity amphoacetates can be obtained via processes utilizing precise pH control during the reaction of imidazoline, or its open-chain derivatives, with alkylating agents, e.g. sodium monochloroacetate. The pH can be controlled by adding the base slowly or automatically in response to a pH metering device to maintain a constant pH, or by a series of staged additions which are calculated to maintain pH within a stated range. The reaction may also be carried out by conducting the initial hydrolysis of the imidazoline ring structure, followed by alkylation.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: September 14, 1999
    Assignee: Rhodia Inc.
    Inventors: Bharat Desai, Peter Lees, Jean-Marc Ricca, David J. Tracy
  • Patent number: 5744063
    Abstract: Imadazoline-based amphoacetates of higher purity, containing essentially negligible amounts of unalkylated amido amines, lower amounts of glycolic acid salts and monochloroacetate salts, superior to currently available conventional amphoacetates, are provided. This is demonstrated by their improved surface-active properties. Lower inherent irritation properties may be expected due to improved purity. The higher purity amphoacetates can be obtained via processes utilizing precise pH control during the reaction of imidazoline, or its open-chain derivatives, with alkylating agents, e.g. sodium monochloroacetate. The pH can be controlled by adding the base slowly or automatically in response to a pH metering device to maintain a constant pH, or by a series of staged additions which are calculated to maintain pH within a stated range. The reaction may also be carried out by conducting the initial hydrolysis of the imidazoline ring structure, followed by alkylation.
    Type: Grant
    Filed: February 18, 1997
    Date of Patent: April 28, 1998
    Assignee: Rhone-Poulenc Inc.
    Inventors: Bharat Desai, Peter Lees, Jean-Marc Ricca, David J. Tracy